Dexlansoprazole
Therapeutic Group
Peptic Ulcer & Gastro-Oesophageal Reflux DiseaseIndication Dosage
Erosive Esophagitis:
- Adult: Tab 60mg Once Daily For Up To 8 Weeks. Maintenance And Relief Of Heartburn; 30 mg Once Daily For Up To 6 Months.
Symptomatic Non-erosive Gastroesophageal Reflux Disease (GERD):
- Adult: Tab 30 mg Once Daily For 4 Weeks.
Content
- Cap 30mg/60mg: Dexlansoprazole Dual Delayed Release (enteric Coated Pellets) Equiv To Dexlansoprazole 30mg/60 Mg
Pregnancy
Use Only If Clearly Needed.
Stability
- Proton Pump Inhibitor (PPI)
Contra Indications
- Hypersensitivity To Any Component Of The Drug, Malignancy, Severe Hepatic Impairment.
Precautions
- Hypersensitivity To Any Component Of The Drug, Malignancy, Severe Hepatic Impairment.
Lactation
- Caution Advised, Avoid
Side Effects
- Diarrhea
- Abdominal Pain
- Nausea
- Upper Respiratory Tract Infection
- Vomiting
- Flatulence
- Hot Flashes
- Contusion
- Oropharyngeal Pain
- Weight Loss.
- Rare: Liver Disorders
- Anaphylaxis And Hypersensitivity Reaction Such As Epidermal Necrolysis
- Pruritus.